Emerging applications of natural language processing for the identification of steatotic liver disease.
作者信息
Kyalwazi Beverly, Louissaint Jeremy
机构信息
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Department of Internal Medicine, Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
出版信息
Hepatol Commun. 2025 Jul 14;9(8). doi: 10.1097/HC9.0000000000000774. eCollection 2025 Aug 1.
Abstract
摘要
相似文献
1
Emerging applications of natural language processing for the identification of steatotic liver disease.自然语言处理在脂肪性肝病识别中的新兴应用
Hepatol Commun. 2025 Jul 14;9(8). doi: 10.1097/HC9.0000000000000774. eCollection 2025 Aug 1.
2
Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease Using Natural Language Processing in a US National Cohort.在美国全国队列中使用自然语言处理识别代谢功能障碍相关脂肪性肝病
Am J Gastroenterol. 2025 Jan 16. doi: 10.14309/ajg.0000000000003321.
3
Cause-specific mortality in patients with steatotic liver disease in the United States.美国脂肪性肝病患者的病因特异性死亡率。
J Hepatol. 2025 May 24. doi: 10.1016/j.jhep.2025.05.013.
4
Steatotic liver disease: what role does alcohol consumption play?脂肪性肝病：饮酒起什么作用？
Minerva Med. 2025 Jul 17. doi: 10.23736/S0026-4806.25.09726-5.
5
Steatotic liver disease arising in an asymptomatic 20-year-old man with panhypopituitarism and elevated transaminases.一名20岁无症状男性，患有全垂体功能减退症且转氨酶升高，出现了脂肪性肝病。
Can Liver J. 2024 Dec 19;7(4):511-516. doi: 10.3138/canlivj-2024-0030. eCollection 2024 Dec.
6
Outcomes of pediatric living donor liver transplantation using steatotic grafts: expanding the donor pool for rising MASLD prevalence.使用脂肪变性移植物进行小儿活体肝移植的结果：为不断上升的代谢相关脂肪性肝病患病率扩大供体库
Hepatol Int. 2025 Jul 18. doi: 10.1007/s12072-025-10851-1.
7
Steatotic liver disease interacts with a polygenic risk score for triglyceride clearance to impact the risk of hypertriglyceridaemia: The Maastricht Study.脂肪性肝病与甘油三酯清除的多基因风险评分相互作用，影响高甘油三酯血症风险：马斯特里赫特研究
Diabetologia. 2025 Jun 27. doi: 10.1007/s00125-025-06479-3.
8
Toward Cross-Hospital Deployment of Natural Language Processing Systems: Model Development and Validation of Fine-Tuned Large Language Models for Disease Name Recognition in Japanese.迈向自然语言处理系统的跨医院部署：用于日语疾病名称识别的微调大语言模型的模型开发与验证
JMIR Med Inform. 2025 Jul 8;13:e76773. doi: 10.2196/76773.
9
Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence.使用可解释人工智能将细胞外囊泡作为代谢功能障碍相关脂肪性肝病分期的生物标志物
World J Gastroenterol. 2025 Jun 14;31(22):106937. doi: 10.3748/wjg.v31.i22.106937.
10
Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in metabolic dysfunction-associated steatotic liver disease.多参数超声用于代谢功能障碍相关脂肪性肝病中肝脂肪变性、纤维化和炎症的无创评估
World J Gastroenterol. 2025 Jul 7;31(25):105518. doi: 10.3748/wjg.v31.i25.105518.
本文引用的文献
1
Assessing the diagnostic accuracy of ChatGPT-4 in the histopathological evaluation of liver fibrosis in MASH.评估ChatGPT-4在MASH肝纤维化组织病理学评估中的诊断准确性。
Hepatol Commun. 2025 Apr 30;9(5). doi: 10.1097/HC9.0000000000000695. eCollection 2025 May 1.
2
Automated identification of incidental hepatic steatosis on Emergency Department imaging using large language models.使用大语言模型在急诊科影像上自动识别偶然发现的肝脂肪变性
Hepatol Commun. 2025 Feb 19;9(3). doi: 10.1097/HC9.0000000000000638. eCollection 2025 Mar 1.
3
Brief Review and Primer of Key Terminology for Artificial Intelligence and Machine Learning in Hypertension.高血压人工智能与机器学习关键术语简述及入门指南
Hypertension. 2025 Jan;82(1):26-35. doi: 10.1161/HYPERTENSIONAHA.123.22347. Epub 2024 Jul 16.
4
Identification of hepatic steatosis among persons with and without HIV using natural language processing.利用自然语言处理技术识别有和无 HIV 感染者的肝脂肪变性。
Hepatol Commun. 2024 Jun 19;8(7). doi: 10.1097/HC9.0000000000000468. eCollection 2024 Jul 1.
5
A natural language processing algorithm accurately classifies steatotic liver disease pathology to estimate the risk of cirrhosis.一种自然语言处理算法可以准确地对脂肪性肝病的病理学进行分类，以估计肝硬化的风险。
Hepatol Commun. 2024 Mar 29;8(4). doi: 10.1097/HC9.0000000000000403. eCollection 2024 Apr 1.
6
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis.美国肝病研究学会关于基于成像的肝纤维化和脂肪变性非侵入性肝病评估的实践指南。
Hepatology. 2025 Feb 1;81(2):672-724. doi: 10.1097/HEP.0000000000000843. Epub 2024 Mar 15.
7
A global research priority agenda to advance public health responses to fatty liver disease.推进应对脂肪肝疾病的公共卫生措施的全球研究优先事项议程
J Hepatol. 2023 Sep;79(3):618-634. doi: 10.1016/j.jhep.2023.04.035. Epub 2023 Jun 20.
8
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.美国肝病研究学会非酒精性脂肪性肝病临床评估与管理实践指南
Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17.
9
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新：非酒精性脂肪性肝病患者肝细胞癌的筛查和监测：专家综述。
Gastroenterology. 2020 May;158(6):1822-1830. doi: 10.1053/j.gastro.2019.12.053. Epub 2020 Jan 30.
Zotero 插件